Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse

Year:

2025

Authors

Heras-Murillo, I; Mañanes, D; Munné, P; Núñez, V; Herrera, J; Catalá-Montoro, M; Alvarez, M; del Pozo, MA; Melero, I; Wculek, SK; Sancho, D

Journal:

Nature Communications

Number:

1

Volume:

16

Init page:

3369

https://doi.org/10.1038/s41467-025-58289-1